Page last updated: 2024-08-23

ng-nitroarginine methyl ester and Parkinson Disease

ng-nitroarginine methyl ester has been researched along with Parkinson Disease in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's1 (14.29)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Fazli-Tabaei, S; Khakpai, F; Zarrindast, MR1
Cadet, P; Neuwirth, LS; Zhu, W1
Ansah, T; Channon, KM; Charlton, C; Gangula, PR; Hale, A; Kalpana, R; Sampath, C; Srinivasan, S1
Agarwal, AK; Chaturvedi, RK; Das, T; Dikshit, M; Ravindran, A; Shukla, Y; Singh, S1
Obata, T; Yamanaka, Y1
Barthwal, MK; Dikshit, M; Srivastava, N1
Cho, KG; Jin, BK; Joe, EH; Kim, J; Kim, SU; Lee, YB; Oh, YJ; Ryu, JK; Shin, WH1

Other Studies

7 other study(ies) available for ng-nitroarginine methyl ester and Parkinson Disease

ArticleYear
Synergistic effect between quinpirole and L-NAME as well as sulpiride and L-arginine on the modulation of anxiety and memory processes in the 6-OHDA mouse model of Parkinson's disease: An isobologram analysis.
    Neurobiology of learning and memory, 2021, Volume: 186

    Topics: Adrenergic Agents; Animals; Anxiety; Arginine; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Therapy, Combination; Enzyme Inhibitors; Male; Memory; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidopamine; Parkinson Disease; Quinpirole; Receptors, Dopamine D2; Sulpiride

2021
Regulation of the Endogenous Opiate Signaling Pathway against Oxidative Stress and Inflammation: A Considerable Approach for Exploring Preclinical Treatment of Parkinson's Disease.
    Pharmacology, 2023, Volume: 108, Issue:6

    Topics: Animals; Dopaminergic Neurons; Humans; Inflammation; Morphine; Naloxone; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Oxidative Stress; Oxidopamine; Parkinson Disease; Rotenone; Signal Transduction

2023
Impairment of Nrf2- and Nitrergic-Mediated Gastrointestinal Motility in an MPTP Mouse Model of Parkinson's Disease.
    Digestive diseases and sciences, 2019, Volume: 64, Issue:12

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; alpha-Synuclein; Animals; Biopterins; Blotting, Western; Colon; Constipation; Disease Models, Animal; Enzyme Inhibitors; Gastric Emptying; Gastrointestinal Motility; Gene Expression Regulation; Heme Oxygenase-1; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; MPTP Poisoning; NF-E2-Related Factor 2; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type I; Parkinson Disease; Parkinsonian Disorders; Tyrosine 3-Monooxygenase

2019
Involvement of nitric oxide in neurodegeneration: a study on the experimental models of Parkinson's disease.
    Redox report : communications in free radical research, 2005, Volume: 10, Issue:2

    Topics: Animals; Brain; Female; Lipopolysaccharides; Male; Neurodegenerative Diseases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitrites; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase

2005
Nitric oxide enhances MPP(+)-induced hydroxyl radical generation via depolarization activated nitric oxide synthase in rat striatum.
    Brain research, 2001, Jun-01, Volume: 902, Issue:2

    Topics: 1-Methyl-4-phenylpyridinium; Allopurinol; Animals; Dopamine; Enzyme Inhibitors; Extracellular Space; Herbicides; Hydroxybenzoates; Hydroxyl Radical; Iron; Iron Chelating Agents; Male; Membrane Potentials; Microdialysis; Neostriatum; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Parkinson Disease; Potassium; Rats; Rats, Wistar

2001
Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in the rat.
    Redox report : communications in free radical research, 2001, Volume: 6, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Corpus Striatum; Disease Models, Animal; Disease Progression; Dopamine; Enzyme Inhibitors; Homovanillic Acid; Male; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley

2001
Trisialoganglioside GT1b induces in vivo degeneration of nigral dopaminergic neurons: role of microglia.
    Glia, 2002, Apr-01, Volume: 38, Issue:1

    Topics: Animals; Antigens, CD; Antigens, Neoplasm; Antigens, Surface; Avian Proteins; Basigin; Blood Proteins; Cell Death; Dopamine; Enzyme Inhibitors; Female; Gangliosides; Gliosis; Immunohistochemistry; Membrane Glycoproteins; Microglia; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Parkinson Disease; Rats; Rats, Sprague-Dawley; Substantia Nigra

2002